报告题目：A road mapfor prioritizing warheads for cysteine targeting covalent inhibitors      

报告人：GyörgyMiklósKeserű教授

报告时间：2019年10月16日（周三）上午09:10-09:40    

报告地点：化工楼南207学术报告厅

报告对象：全校感兴趣的老师和学生

主办单位：yd12399云顶集团

报告人简介：

GyörgyM. Keserű obtained his Ph.D. at Budapest, Hungary and joined Sanofi heading achemistry research lab. He moved to Gedeon Richter in 1999 as the Head ofComputer-aided Drug Discovery. He earned D.Sc. from the Hungarian Academy ofScience in 2003 and he was invited for a research professorship at the BudapestUniversity of Technology and Economics. Since 2007 he was appointed as the Headof Discovery Chemistry at Gedeon Richter. He contributed to the discovery ofthe antipsychoticVraylar® (cariprazine) that has been approved and marketedfrom 2016 in US and EU. He served as a director general of the Research Centrefor Natural Sciences (RCNS) at the Hungarian Academy of Sciences. From 2015 heis heading the Medicinal Chemistry Research Group at RCNS. His researchinterests include medicinal chemistry, drug design. He has published over 230papers and more than 10 books and book chapters. György was awarded by theprestigious Overton and Meyer Award of the European Federation of MedicinalChemistry. He has been elected as Fellow of the Royal Society of Chemistry andas Corresponding member of the Hungarian Academy of Sciences.